QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 morgan-stanley-maintains-overweight-on-cvs-health-raises-price-target-to-89

Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $82 to...

 goldman-sachs-initiates-coverage-on-cvs-health-with-buy-rating-announces-price-target-of-91

Goldman Sachs analyst Scott Fidel initiates coverage on CVS Health (NYSE:CVS) with a Buy rating and announces Price Target ...

 stocks-tumble-as-trump-mulls-massive-china-tariffs-whats-moving-markets-friday

The stock market stumbled Friday after President Donald Trump threatened a sweeping increase in tariffs on Chinese imports, sen...

 deal-dispatch-confluent-considers-sale-rothschild-exits-the-economist-cvs-feels-the-pain

Confluent explores a sale, Rothschild exits The Economist, Helsing buys Blue Ocean, Zimmer expands robotics, and Omnicare files...

 mizuho-maintains-outperform-on-cvs-health-raises-price-target-to-88

Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $76 to $88.

 wells-fargo-maintains-overweight-on-cvs-health-raises-price-target-to-103

Wells Fargo analyst Stephen Baxter maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $84 to...

 pfizers-trumprx-pact-sends-shockwaves-why-unitedhealth-lilly-and-cvs-cant-look-away

Pfizer's deal with TrumpRx for steep drug discounts could impact UnitedHealth, Eli Lilly, and CVS. Here's how...

 cvs-healths-aetna-announces-2026-medicare-advantage-products-with-benefits-and-programs-reflecting-diverse-needs-of-members

Providing access to affordable care$0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1,$0 copay for colo...

 aetna-expands-hospital-program-to-cut-readmissions

Aetna, a CVS Health unit, is expanding its Clinical Collaboration program to 10 hospitals to cut readmissions.

 cvs-healths-omnicare-initiates-voluntary-court-supervised-chapter-11-process-to-resolve-issues-related-to-recent-litigation-in-us-district-court-for-southern-district-of-new-york

Company Intends to Use Process to Implement a Standalone Restructuring or Sale StrategyRemains Focused on Delivering Safe and R...

 aetna-a-cvs-health-company-announced-it-will-scale-the-aetna-clinical-collaboration-program-to-ten-hospitals-by-year-end

Aetna Clinical Collaboration Program on-track to implement in ten hospitals by end of 2025Early indicators show high member eng...

 stock-of-the-day-is-cvs-headed-higher

CVS Health Corporation reverses off of support around the $70 level. There is support at this level because it was resistance.

 mark-cuban-exposes-how-wholesalers-force-pharmacies-into-near-exclusive-deals-detailing-pbms-stranglehold-on-drug-pricing

Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on pres...

 bernstein-maintains-market-perform-on-cvs-health-raises-price-target-to-77

Bernstein analyst Lance Wilkes maintains CVS Health (NYSE:CVS) with a Market Perform and raises the price target from $72 to...

 barclays-maintains-overweight-on-cvs-health-raises-price-target-to-87

Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $80 to $87.

Core News & Articles

https://www.hhs.gov/press-room/hhs-expands-access-affordable-catastrophic-health-coverage.html

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION